Background Image
Table of Contents Table of Contents
Previous Page  61 / 74 Next Page
Information
Show Menu
Previous Page 61 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019

AFRICA

127

online ahead of print. DOI: (8):15-20.

25. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L,

et al

.

Long-term mortality after pre-eclampsia.

Epidemiology

2005;

16

(1):

206–215.

26. Leslie M, Briggs L. Pre-eclampsia and the risk of future vascular

disease and mortality: a review.

J Midwifery Womens Health

2016;

61

(3):

315–324.

27. Dunietz GL, Strutz KL, Holzman C, Tian Y, Todem D, Bullen BL,

et al

.

Moderately elevated blood pressure during pregnancy and odds of hyper-

tension later in life the POUCHmoms longitudinal study.

Br J Obstet

Gynaecol

2017; doi: 10.1111/1471-0528.14556. [Epub ahead of print].

28. Yang JJ, Lee S-A, Choi J-Y, Song M, Han S, Yoon H-S,

et al

.

Subsequent risk of metabolic syndrome in women with a history of pre-

eclampsia: data from the Health Examinees Study.

J Epidemiol

2015;

25

(4): 281–288.

29. Tooher J, Thornton C, Makris A, Ogle R, Korda A, Hennessy A. All

hypertensive disorders of pregnancy increase the risk of future cardio-

vascular disease.

Hypertension

2017;

70

(4): 798–803.

30. Grace T, Bulsara M, Pennell C, Hands B. Maternal hypertensive diseases

negatively affect offspring motor development.

Pregnancy Hypertens

2014;

4

(3): 209–214.

31. Lawlor D, Macdonald-Wallis C, Fraser A, Nelson S, Hingorani A,

Davey Smith G,

et al

. Cardiovascular biomarkers and vascular func-

tion during childhood in the offspring of mothers with hypertensive

disorders of pregnancy: findings from the Avon Longitudinal Study of

Parents and Children.

Eur Heart J

2012;

33

(3): 335–345.

32. Brown MA, Mangos G, Davis G, Homer C. The natural history of

white coat hypertension during pregnancy.

Br J Obstet Gynaecol

2005;

112

(5): 601–606.

33. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hyper-

tension become pre-eclampsia?

Br J Obstet Gynaecol

1998;

105

(11):

1177–1184.

34. Lee-Ann H, T, Brown MA, Mangos GJ, Davis GK. Transient gesta-

tional hypertension: Not always a benign event.

Pregnancy Hypertens

2012;

2

(1): 22–27.

35. Bowyer L, Brown MA, Jones M. Forearm blood flow in pre-eclampsia.

Br J Obstet Gynaecol

2003;

110

(4): 383–391.

36. Quinn M. Korotkoff’s sounds in pregnancy.

Ultrasound Obstet Gynecol

1995;

6

(1): 58–61.

37. Jeyabalan A, Kerchner L, Fisher MC, McGuane JT, Doty KD, Conrad

KP. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue

inhibitors in small arteries from pregnant and relaxin-treated nonpreg-

nant rats.

J Appl Physiol

2006;

100

(6): 1955–1963.

38. Samuel CS, Cendrawan S, Gao XM, Ming Z, Zhao C, Kiriazis H,

et al.

Relaxin remodels fibrotic healing following myocardial infarction.

Lab

Invest

2011;

91

(5): 675–690.

39. Conrad KP, Shroff SG. Effects of relaxin on arterial dilation, remod-

eling, and mechanical properties.

Curr Hypertens Rep

2011;

13

(6):

409–420.

40. Leo CH, Jelinic M, Ng HH, Marshall SA, Novak J, Tare M,

et al

.

Vascular actions of relaxin: nitric oxide and beyond

. Br J Pharmacol

2017;

174

(10): 1002–1014.

41. Ngene NC, Moodley J. Physiology of blood pressure relevant to manag-

ing hypertension in pregnancy.

J Matern Fetal Neonatal Med

2017: 1–10.

doi: 10.1080/14767058.2017.1404569. [Epub ahead of print].

42. Monga M, Mastrobattista JM. Maternal cardiovascular, respiratory,

and adaptation to pregnancy. In: Creasy RK, Resnik R, Iams JD,

Moore CR, Greene MF, eds.

Creasy and

Resnik’s Maternal-fetal

Medicine: Principles and Practice

. China: Saunders, an imprint of

Elsvier Inc, 2014.

43. Salleh S, Quinn M. Korotkoff’s sounds in pregnancy.

J Hypertens

2005;

23

(7): 1433.

44. Agra KF, Pontes IEA, da Silva J R Jr, Figueiroa JN, Clough GF, Alves

JGB. Impaired neurovascular reactivity in the microvasculature of

pregnant women with preeclampsia.

Microcirculation

2017;

24

(7): doi:

10.1111/micc.12383.

45. Kao CK, Morton JS, Quon AL, Reyes LM, Lopez-Jaramillo P, Davidge

ST. Mechanism of vascular dysfunction due to circulating factors in

women with pre-eclampsia.

Clin Sci

(Lond) 2016;

130

(7): 539–549.

46. Morris EA, Hale SA, Badger GJ, Magness RR, Bernstein IM. Pregnancy

induces persistent changes in vascular compliance in primiparous

women.

Am J Obstet Gynecol

2015;

212

(5): 633.e1–6.

47. Vollebregt K, van Leijden L, Westerhof B, Boer K, Wolf H. Arterial

stiffness is higher in early pregnancy in women, who will develop pre-

eclampsia.

Am J Obstet Gynecol

2008;

199

(6, Supplement A): S203.

48. FranzMB, BurgmannM, Neubauer A, Zeisler H, Sanani R, Gottsauner-

Wolf M,

et al

. Augmentation index and pulse wave velocity in normo-

tensive and pre-eclamptic pregnancies.

Acta Obstet Gynecol Scand

2013;

92

(8): 960–966.

49. Bibbins-Domingo K, Grossman DC, Curry SJ, BarryMJ, Davidson KW,

et al

. US Preventive Services Task Force. Screening for Preeclampsia: US

Preventive Services Task Force Recommendation Statement.

J Am Med

Assoc

2017;

317

(16): 1661–1667.

50. Tranquilli AL, Giannubilo S, Dell’Uomo B, Corradetti A. Prediction of

gestational hypertension or intrauterine fetal growth restriction by mid-

trimester 24-h ambulatory blood pressure monitoring.

Int J Gynaecol

Obstet

2004;

85

(2): 126–131.

51. Singh RK, Verma NS, Barnwal N, Gupta HP, Singh U, Mehrotra S,

et al

. Studies on circadian pattern of blood pressure in normotensive

pregnanct women and preeclampsia. In memory of late Professor Franz

Halberg, Father of Chronobiology.

World Heart J

2014;

6

(1): 21–28.

52. Udenze IC, Arikawe AP, Makwe CC, Olowoselu OF. A prospective

cohort study on the clinical utility of second trimester mean arte-

rial blood pressure in the prediction of late-onset preeclampsia among

Nigerian women

. Niger J Clin Pract

2017;

20

(6): 741–745.

53. Lee W, Rokey R, Miller J, Cotton DB. Maternal hemodynamic effects of

uterine contractions by M-mode and pulsed-Doppler echocardiography.

Am J Obstet Gynecol

1989;

161

(4): 974–977.

54. El Ayadi AM, Nathan HL, Seed PT, Butrick EA, Hezelgrave NL,

Shennan AH,

et al

. Vital sign prediction of adverse maternal outcomes

in women with hypovolemic shock: the role of shock index.

PLoS One

2016;

11

(2): e0148729.

55. Jones RM, Knight PR, Hill AB. Rate pressure product.

Anaesthesia

1980;

35

: 1010–1021.

56. Pepper MG, Crawley BC. Rate pressure product.

Anaesthesia

1984;

39

(2): 192–193.

57. Douglas K, Redman C. Eclampsia in the United Kingdom.

Br Med J

1994;

309

: 1395–1400.

58. Moodley J, Kalane G. A review of the management of eclampsia: practi-

cal issues.

Hypertens Pregnancy

2006;

25

(2): 47–62.

59. Davis GK, Roberts LM, Mangos GJ, Brown MA. Comparisons of

auscultatory hybrid and automated sphygmomanometers with mercu-

ry sphygmomanometry in hypertensive and normotensive pregnant

women: parallel validation studies.

J Hypertens

2015;

33

(3): 499–505.

60. Al-Shaikh B, Stacey S.

Essentials of Anaesthetic Equipment

. 4th edn.

Edinburgh: Elsevier, 2013.

61. Ward M, Langton JA. Blood pressure measurement.

Contin Educat

Anaesth Crit Care Pain

2007;

7

(4): 122–126.

62. Ngene NC, Moodley J. Blood pressure measurement and rapid acting

antihypertesnsives for severe hypertension in pregnancy.

Obstet Gynaecol